Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:891-894
Published online before print September 29, 2003, doi: 10.1161/01.HYP.0000095981.92542.F6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/5/891    most recent
01.HYP.0000095981.92542.F6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramsay, J. E.
Right arrow Articles by Sattar, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramsay, J. E.
Right arrow Articles by Sattar, N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Risk Pregnancy
Related Collections
Right arrow Clinical Studies
Right arrow Other hypertension

(Hypertension. 2003;42:891.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Paradoxical Elevation in Adiponectin Concentrations in Women With Preeclampsia

Jane E. Ramsay; Nigel Jamieson; Ian A. Greer; Naveed Sattar

From the Division of Developmental Medicine, University of Glasgow, Glasgow Royal Infirmary University NHS Trust, Glasgow, Scotland.

Correspondence to Naveed Sattar, Department of Pathological Biochemistry, Glasgow Royal Infirmary, Glasgow, G31 2ER, Scotland. E-mail nsattar{at}clinmed.gla.ac.uk

Adiponectin is a recently identified, insulin-sensitizing and anti-inflammatory protein released by adipocytes, which is paradoxically reduced in obesity. It suppresses endothelial activation. Physiological insulin resistance occurs in normal pregnancy and is exaggerated in women with preeclampsia (PE), together with enhanced inflammatory and endothelial activation. Women with increased body mass index (BMI) and insulin resistance are predisposed to PE. We hypothesized that adiponectin concentrations are reduced in normal pregnancy compared with postpartum values and further reduced in women with PE. Fifteen women with PE and 30 control subjects with similar first trimester BMI had adiponectin concentrations measured in the third trimester; postpartum measurements were repeated in 16 control subjects. Adiponectin concentration in healthy pregnant women correlated inversely with early pregnancy BMI (r=-0.47, P=0.01) and fasting insulin concentrations (r=-0.58, P=0.001). However, adiponectin concentrations did not differ significantly in pregnancy and postpartum samples (mean change, -0.15 µg/mL; 95% CI, -2.28 to 1.98, P=0.88). Plasma adiponectin concentrations were markedly elevated (P=0.01) in women with PE (mean, 21.6; SD, 8.18 µg/mL) compared with control subjects (mean, 14.7; SD, 7.06 µg/mL). Moreover, in PE, adiponectin concentrations did not correlate with first trimester BMI or insulin or with serum urate or creatinine concentrations or urinary protein levels. We conclude that plasma adiponectin concentrations are not elevated in normal human pregnancy and paradoxically elevated (by 47%) in women with PE. This may be secondary to exaggerated nonspecific adipocyte lipolysis or as a physiological response to enhance fat utilization and attenuate endothelial damage. Future studies should determine whether adiponectin concentrations help improve prediction of PE.


Key Words: adipose tissue • insulin resistance • pregnancy • endothelium • preeclampsia




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Fasshauer, T. Waldeyer, J. Seeger, S. Schrey, T. Ebert, J. Kratzsch, U. Lossner, M. Bluher, M. Stumvoll, R. Faber, et al.
Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function
Eur. J. Endocrinol., February 1, 2008; 158(2): 197 - 201.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Haugen and C. A. Drevon
Activation of Nuclear Factor-{kappa}B by High Molecular Weight and Globular Adiponectin
Endocrinology, November 1, 2007; 148(11): 5478 - 5486.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Masuyama, H. Nakatsukasa, N. Takamoto, and Y. Hiramatsu
Correlation between Soluble Endoglin, Vascular Endothelial Growth Factor Receptor-1, and Adipocytokines in Preeclampsia
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2672 - 2679.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Sattar, G. Wannamethee, N. Sarwar, J. Tchernova, L. Cherry, A. M. Wallace, J. Danesh, and P. H. Whincup
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Circulation, August 15, 2006; 114(7): 623 - 629.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. M. Roberts and H. Gammill
Insulin Resistance in Preeclampsia
Hypertension, March 1, 2006; 47(3): 341 - 342.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Haugen, T. Ranheim, N. K. Harsem, E. Lips, A. C. Staff, and C. A. Drevon
Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E326 - E333.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. A. Lawlor, G. Davey Smith, S. Ebrahim, C. Thompson, and N. Sattar
Plasma Adiponectin Levels Are Associated with Insulin Resistance, But Do Not Predict Future Risk of Coronary Heart Disease in Women
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5677 - 5683.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
E. Kajantie, R. Kaaja, O. Ylikorkala, S. Andersson, and H. Laivouri
Adiponectin Concentrations in Maternal Serum: Elevated in Preeclampsis But Unrelated to Insulin Sensitivity
Reproductive Sciences, September 1, 2005; 12(6): 433 - 439.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
R. D'Anna, G. Baviera, F. Corrado, D. Giordano, A. Di Benedetto, and V. M. Jasonni
Plasma Adiponectin Concentration in Early Pregnancy and Subsequent Risk of Hypertensive Disorders
Obstet. Gynecol., August 1, 2005; 106(2): 340 - 344.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. P. Thyfault, E. M. Hedberg, R. M. Anchan, O. P. Thorne, C. M. Isler, E. R. Newton, G. L. Dohm, and J. E. deVente
Gestational Diabetes is Associated with Depressed Adiponectin Levels
Reproductive Sciences, January 1, 2005; 12(1): 41 - 45.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Kajantie, T. Hytinantti, P. Hovi, and S. Andersson
Cord Plasma Adiponectin: A 20-Fold Rise between 24 Weeks Gestation and Term
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4031 - 4036.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Shinohara, A. Wakatsuki, K. Watanabe, N. Ikenoue, T. Fukaya, N. Sattar, J. Ramsey, N. Jamieson, and I. A. Greer
Plasma Adiponectin Concentrations in Women With Preeclampsia * Response: Adiponectin Concentrations in Preeclampsia
Hypertension, April 1, 2004; 43(4): e17 - e17.
[Full Text] [PDF]